PRODUCTS

Location:
Location:

AOH1996
Submit to
Product detail
On August 3, 2023, City of Hope, a U.S. cancer research organization, released a statement claiming that its scientists are developing a "targeted chemotherapy drug (AOH1996) that kills all solid malignant tumors (carcinomas)" and is currently in Phase 1 clinical trials.

In an official press release, City of Hope wrote that AOH1996 has been shown to be effective in preclinical studies for the treatment of breast, prostate, brain, ovarian, cervical, skin, and lung cancer cells, and that it can be taken orally, is metabolically stable, and can inhibit tumor growth as a stand-alone treatment or in combination without causing detectable side effects. Side effects.